Posted by Michael Wonder on 12 Oct 2017
New treatment option for people with gastro-intestinal cancer
12 October 2017 - More people will be able to receive regorafenib now that NICE has said it should move out of the Cancer Drugs Fund and into routine NHS funding.
Regorafenib can be offered as an option to treat people who have gastro-intestinal stromal tumours (GIST) that have spread to other parts of the body, cannot be treated by surgery, or if the person is unable to take other treatments.
The drug was previously only available to patients through the Cancer Drugs Fund but now, after NICE’s recommendation, it will be routinely available on the NHS.
